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Poliomyelitis Eradication — Continued 
eradication has been the participation of eight officers in the CDC Stop Transmission 
of Polio (STOP) initiative. STOP mobilizes additional trained personnel for 3-month 
polio eradication assignments in high-priority countries. STOP officers in Nepal 
worked with RSOs to strengthen AFP surveillance, plan NIDs and sub-NIDs, and mobi 
lize other sectors in support of polio eradication. 
Fewer than 440 days remain to reach the target for global polio eradication by the 
end of 2000. Substantial and rapid improvement in NIDs and AFP surveillance has 
brought Nepal closer to the goal of eradication**. Priorities for polio eradication in 
Nepal in 1999 and 2000 include 1) execution of high-quality NIDs and supplemental 
vaccination campaigns targeting high risk areas and populations (five monthly rounds 
will be synchronized with India during November 1999-March 2000); 2) maintenance 
of sensitive AFP surveillance, especially in the densely populated districts bordering 
India; and 3) improving routine OPV3 coverage. 
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The West Nile virus (WNV) encephalitis outbreak continues to wane in the North 
east with the onset of cooler temperatures and continued vector-control operations. 
This report updates the progress of the ongoing investigation. Since the last published 
update (7 ), five additional domestic human cases and one international case have 
been identified. As of October 19, 56 (31 confirmed and 25 probable) cases of WNV 
'infection have been identified, including seven deaths (Figure 1). The date of onset of 
the latest cases was September 22. The international case was a Canadian citizen who 
had visited the New York City (NYC) area in late August who had onset of fatal 
encephalitis on September 5. Active surveillance for human encephalitis cases in 
Connecticut and New Jersey has not detected any WNV cases. 
Surveillance for WNV in mosquitoes and birds continues. As of October 19, 
11 pools collected during September 12-October 4 of Culex spp. mosquitoes, positive 
for WNV, have been identified from NYC and Nassau and Suffolk counties. Pools of 
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FIGURE 1. Number of seropositive cases of West Nile virus, by week of onset — 
New York, 1999 
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Culex and Aedes vexans mosquitoes collected during early to mid-September in 
Hudson County, New Jersey, tested positive for WNV by reverse transcriptase poly 
merase chain reaction (RT-PCR). Birds that tested positive for WNV now have been 
identified by RT-PCR on postmortem brain tissue from New York (NYC boroughs of 
Bronx, Brooklyn, Manhattan, Queens, and Staten Island; and Nassau, Orange, Rock 
land, Saratoga, Suffolk, and Westchester counties). New Jersey (Bergen, Burlington, 
Essex, Hudson, Hunterdon, Middlesex, Monmouth, Morris, Passaic, Somerset, Union, 
and Warren counties), and Connecticut (Fairfield County). In addition, postmortem 
brain tissue from birds from Fairfield and New Haven counties, Connecticut, have 
been reported as positive in culture for WNV by the Connecticut Department of Health. 
Although most WNV-positive birds have been American crows, infections also have 
been confirmed in other native species, including the ring-billed gull, yellow-billed 
cuckoo, rock dove, sandhill crane, fish crow, blue jay, bald eagle, laughing gull, black 
crowned night heron, mallard, American robin, red-tailed hawk, and broad-winged 
hawk. 
Laboratory studies conducted at CDC have identified the etiologic agent responsi 
ble for the human arboviral encephalitis outbreak in the NYC area as WNV. Confirma 
tion of the genetic identity as WNV has been performed independently by 
collaborators at the United States Army Medical Research Institute for Infectious Dis 
eases. WNV-specific gene sequences have been amplified by RT-PCR performed on 
RNA extracted from autopsy specimens (six case-patients). Sequences of genome 
fragments of WNV isolated from dead birds and mosquitoes are identical to gene 
sequences from the human autopsy specimens. Antigenic mapping of these isolates 
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has been performed using a panel of monoclonal antibodies (Mabs) developed by 
CDC or provided by collaborators at the University of Queensland, Australia. These 
envelope (E)-glycoprotein specific Mabs, capable of distinguishing WN, Kunjin, and 
St. Louis encephalitis viruses, confirmed the sequence identification of these isolates 
as WNV. 
Reported by: A Fine, MD, M Layton, MD, J Miller, MD, D Cimini, MPH, MC Vargas, DVM, 
A Inglesby, MD, the New York City Outbreak Investigation Team, N Cohen, MD; I Weisfuse, MD; 
A Ramon, MD, I Poshni, PhD, H Stirling, MPH, New York City Dept of Health; T McNamara, 
DVM, Wildlife Conservation Society, New York City; A Huang, MD, A Rosenberg, MD, P Yang 
Lewis, MPH, HN Adel, MD, Westchester County Health Dept, New Rochelle; M Sherman, 
G Terillion, B Smith, R Porter, A Greenberg, MD, KA Gaffney, MD, Nassau County Dept of Health 
and Public Works; A Novello, MD, D White, PhD, D Morse, MD, K Spitalny, MD, R Gallo, S Wong, 
MD, L Grady, MD, M Eidson, DVM, B Wallace, MD, P Smith, MD, State Epidemiologist, New 
York State Dept of Health. M Cartter, MD, R Nelson, DVM, J Hadler, MD, State Epidemiologist, 
Connecticut Dept of Public Health; T Andreadis, PhD, Connecticut Agricultural Experiment Sta 
tion. J Blumenstock, J Degraaf, F Sorhage, DVM, C Campbell, DVM, J Brook, MD, M Gerwell, 
MD, D Adams, K Bruder, R Kent, R Eisner, DVM, N Halpern, DVM, New Jersey Dept of Agricul 
ture; D Roscoe, DVM, New Jersey Dept of Environmental Protection; E Bresnitz, MD, State 
Epidemiologist, New Jersey Dept of Health and Senior Svcs. W Crans, PhD, Rutgers Univ, New 
Brunswick, New Jersey. J Mackenzie, PhD, R Hall, PhD, J Sherret, MSc, Univ of Queensland, 
Australia. H Artsob, PhD, Laboratory Centre for Disease Control, Health Canada. J Smith, PhD, 
M Parker, PhD, K Steele, DVM, United States Army Medical Research Institute for Infectious 
Diseases; National Veterinary Svcs Laboratories, Animal and Plant Health Inspection Svc, US 
Dept of Agriculture, Ames, Iowa. Infectious Disease Pathology Activity, Div of Viral and Rick 
ettsial Diseases, National Center for Infectious Diseases; Arbovirus Diseases Br, Div of 
Vector-Borne Infectious Diseases, National Center for Infections Diseases; and EIS officers, CDC. 
Editorial Note: The dates of onset of illness for laboratory-positive cases of WNV 
infection suggest that the outbreak peaked in late August. There have been no recog 
nized cases of WNV infection with an onset date after September 22. WNV encephali 
tis has an incubation period of 5-15 days. The latest cases occurred outside NYC in 
Nassau and Westchester counties, which implemented mosquito-control measures 
later than NYC. Collectively, these data suggest that control measures, combined with 
cooler temperatures, have been effective in reducing the transmission cycle in nature 
and limiting further illnesses in humans. However, it is important to continue to rec 
ommend personal protective measures during outdoor activity at dusk and at night 
until the onset of cold weather in the affected areas (7). 
The identification of WNV in birds from Orange and Saratoga counties. New York 
City, and Burlington County, New Jersey, may represent an extension northward and 
southward of the known area of natural transmission between birds and mosquitoes, 
but for this to be the case, either demonstration of WNV in vector mosquito popula 
tions or demonstration of neutralizing antibodies against WNV in resident birds is 
needed because these birds may have been infected elsewhere. The current known 
geographic distribution of infected dead birds is in counties surrounding the western 
half of Long Island Sound. 
Serum samples collected from migrant and resident birds in several states will 
be analyzed for antibody to WNV. States included in this survey are New York, New 
Jersey, Maryland, Virginia, North Carolina, South Carolina, Georgia, and Florida. Col 
laborators in this survey include university ornithologists, state wildlife biologists, and 
state health departments. In addition, wildlife and health officials in all mid-Atlantic 
and southeastern states have been alerted to investigate reports of unusual clusters of 
dead birds. 
(Continued on page 955) 
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All state epidemiologists have been informed of the characteristics of this outbreak 
and encouraged to enhance surveillance for cases of human encephalitis. Monitoring 
of mosquitoes and birds has been increased in several states with existing vector 
control programs. Training to institute programs for arbovirus and mosquito vector 
surveillance will be offered to states without programs, beginning with Atlantic coast 
states. In addition, the emerging infections sentinel networks coordinated by the Infec 
tious Diseases Society of America (IDSA EIN) and the International Society of Travel 
Medicine (GeoSentinel) are assisting case-finding efforts to define the extent of the 
outbreak in the United States. 
A previous publication indicated that the New York virus was more closely related 
to Kunjin virus (2). Data in this report based on phylogenetic analysis comparing pub 
lished E-glycoprotein sequences from WNVs and other flaviviruses, including Kunjin, 
St. Louis encephalitis, and Japanese encephalitis indicate that the New York virus is 
WN. Complete genome sequencing of multiple WNV isolates is in progress. 
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Notice to Readers 
Update: Changes to MMWR 
Continuing Education Data Management System 
MMWR Recommendations and Reports first published a Continuing Education 
(CE) component on October 16, 1998. Since then, eight additional CE programs have 
been published in MMWR Recommendations and Reports to provide continuing 
medical education (CME), continuing nursing education (CNE), and continuing educa 
tion unit (CEU) credits for physicians, nurses, and other health-care professionals at 
no cost to the user. Approximately 35,000 examinations have been submitted in print 
or electronically by MMWR readers. Because of the unexpectedly large response to 
the program, reviewing print examinations and mailing certificates to MMWR readers 
have been delayed. 
To address the backlog in processing previously submitted examinations, and to 
effectively manage a program of this size, MMWR has installed a new examination 
management system. The new system speeds processing of examinations submitted 
by mail and allows the user to complete tests and receive credit through the World 
Wide Web (http://www2.cdc.gov/mmwr/cme/conted.html). To reduce the costs of 
this free service, MMWR readers are encouraged to use the online examinations. The 
new system will require prior users of the online system to re-register. Users who 
registered and took examinations online before October 21, 1999, will not be able to 
view their complete transcripts until the old database is merged with the new 
database, which should be completed by January 2000. Questions concerning the 
change should be sent by e-mail to the continuing education coordinator at 
mmwrce@cdc.gov. 
